Endocrinology News and Research

Latest Endocrinology News and Research

Amedica receive FDA clearance for multi-level cervical interbody cage indications

Amedica Corporation, a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that the U.S. Food and Drug Administration has expanded the indications of Amedica’s silicon nitride interbody fusion products to include multi-level cervical treatment.

4 Feb 2015

Two genetic mutations can interact to reduce risk for heart attack

Researchers have determined that two mutations on a single gene can interact in a way that lowers the carrier's risk for a heart attack.

4 Feb 2015

Researchers are one step closer to devising an approach to identify pancreatic cancer earlier

Pancreatic cancer affects approximately 46,000 people each year in the United States and ranks fourth among the leading causes of cancer-related deaths. Only about 6 percent of individuals with pancreatic cancer will live five years after their diagnosis.

3 Feb 2015

Isis announces top-line results from ISIS-PTP1B Rx Phase 2 study in type 2 diabetes patients

Isis Pharmaceuticals, Inc. announced today top-line results from a Phase 2 study of ISIS-PTP1B Rx in patients with type 2 diabetes. In the Phase 2 study patients treated with ISIS-PTP1B Rx achieved statistically significant reductions in body weight and hemoglobin A1c (HbA1c).

3 Feb 2015

Study shows changes in kidney function among sugarcane workers in northwestern Nicaragua

Sugarcane workers in northwestern Nicaragua experienced a decline in kidney function during the harvest, with field workers at greatest risk, suggesting that heat stress or other occupational factors may be playing a role in the high rates of chronic kidney disease in the region, a new study led by Boston University School of Public Health researchers shows.

3 Feb 2015

Study looks at effect of probiotic capsule intervention on metabolic health among women with GDM

In a study to be presented on Feb. 5 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the effect of a probiotic capsule intervention on maternal metabolic parameters and pregnancy outcomes among women with gestational diabetes.

3 Feb 2015

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.

3 Feb 2015

Ildong Pharmaceutical to market BELVIQ (lorcaserin HCl) for weight management in South Korea

Arena Pharmaceuticals, Inc. today announced that Ildong Pharmaceutical Co., Ltd., has informed Arena that the Ministry of Food and Drug Safety has approved BELVIQ (lorcaserin HCl) for marketing for weight management in South Korea. Ildong will market and distribute BELVIQ in South Korea under its marketing and supply agreement with Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, or Arena GmbH.

3 Feb 2015

Researchers to highlight impact of maternal glycemia on childhood obesity at The Pregnancy Meeting

In a study to be presented on Feb. 5 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the impact of maternal glycemia on childhood obesity and metabolic dysfunction.

3 Feb 2015

Not all ARB drugs are equally effective at treating heart failure, reveals NSU researcher

Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure. But it turns out not all ARBs are created equally, according to one Nova Southeastern University researcher's findings.

3 Feb 2015

National Centre for Healthcare Photonics to be located in North East of England

One of the most interesting and fastest developing areas in healthcare is the use of light to diagnose and treat medical conditions and illnesses, collectively known as Healthcare Photonics. It includes a range of new phototherapies as well as bio-medical imaging and in vitro diagnostics. The area offers huge potential for the UK and the global healthcare sector. Applications are wide ranging from wound, skin and cancer care to niche applications in neurology and ophthalmology.

2 Feb 2015

Children's Hospital of Philadelphia invited to Obama's announcement of Precision Medicine Initiative

At the invitation of the White House, The Children's Hospital of Philadelphia (CHOP) sent two special guests to President Barack Obama's announcement today of the Precision Medicine Initiative: Dr. Steven M. Altschuler, CHOP's chief executive officer, and 9-year-old patient Emily Whitehead, now cancer-free thanks to a personalized treatment called T cell therapy, developed at CHOP.

2 Feb 2015

IRIDEX Cyclo G6 Laser System receives FDA clearance for treatment of glaucoma

IRIDEX Corporation today announced that it has received clearance from the U.S. Food and Drug Administration to market its first laser system designed solely for use in treating glaucoma and its symptoms. Specifically, the Company was granted 510(k) clearance for the IRIDEX Cyclo G6 Laser System (with delivery devices).

2 Feb 2015

RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

RTI Health Solutions, a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity.

2 Feb 2015

U.S. Supreme Court to hear arguments in landmark case aiming at Affordable Care Act

On March 4, the U.S. Supreme Court will hear oral arguments in King v. Burwell, a landmark case that takes aim at President Obama's Affordable Care Act (ACA).

2 Feb 2015

Study clarifies association between metformin use and lung cancer risk

Among nonsmokers who had diabetes, those who took the diabetes drug metformin had a decrease in lung cancer risk, according to a study in Cancer Prevention Research, a journal of the American Association for Cancer Research, by Lori Sakoda, PhD, MPH, research scientist at the Kaiser Permanente Division of Research in Oakland, California.

2 Feb 2015

Researchers are developing stress-eating smartphone app with NIH support

Researchers at UMass Medical School and Worcester Polytechnic Institute are developing a stress-eating smartphone app that will help users better understand why they overeat, with the support of a $2 million award from the National Institutes of Health.

2 Feb 2015

EarlyBird study that tracks child-to-adult lifestyle receives financial support

A unique study which has followed 300 young people from age five since 2000, has received backing for a third phase which will see it become the first study of its kind in the world to track the same group from childhood to adulthood.

2 Feb 2015

Study: About one-third of teens, young adults face social barriers to diabetes management

Managing type 1 diabetes is a never-ending task that requires multiple blood glucose tests, carbohydrate calculations and insulin injections or infusions. This constant effort to control the disease is daunting at any age - and it's especially challenging for teens and young adults.

2 Feb 2015

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Improving access to care is an important focus at Meridian Health, and a new partnership with Jersey Coast Vascular Institute is making high quality vascular services more readily available for local residents.

2 Feb 2015

Endocrinology News and Research

Latest Endocrinology News and Research

Amedica receive FDA clearance for multi-level cervical interbody cage indications

Two genetic mutations can interact to reduce risk for heart attack

Researchers are one step closer to devising an approach to identify pancreatic cancer earlier

Isis announces top-line results from ISIS-PTP1B Rx Phase 2 study in type 2 diabetes patients

Study shows changes in kidney function among sugarcane workers in northwestern Nicaragua

Study looks at effect of probiotic capsule intervention on metabolic health among women with GDM

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Ildong Pharmaceutical to market BELVIQ (lorcaserin HCl) for weight management in South Korea

Researchers to highlight impact of maternal glycemia on childhood obesity at The Pregnancy Meeting

Not all ARB drugs are equally effective at treating heart failure, reveals NSU researcher

National Centre for Healthcare Photonics to be located in North East of England

Children's Hospital of Philadelphia invited to Obama's announcement of Precision Medicine Initiative

IRIDEX Cyclo G6 Laser System receives FDA clearance for treatment of glaucoma

RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

U.S. Supreme Court to hear arguments in landmark case aiming at Affordable Care Act

Study clarifies association between metformin use and lung cancer risk

Researchers are developing stress-eating smartphone app with NIH support

EarlyBird study that tracks child-to-adult lifestyle receives financial support

Study: About one-third of teens, young adults face social barriers to diabetes management

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Endocrinology News and Research

Latest Endocrinology News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in